Efinaconazole

DEA Class; Rx

Common Brand Names; Jublia

• Antifungals, Topical

Topical azole antifungal solution
Used for the treatment of onychomycosis of the toenails in adults and pediatric patients 6 years and older
Onychocryptosis (ingrown toenail) was the most frequently reported adverse event during clinical trials

—

Ingrown toenail (2.3%)

Application site dermatitis (2.2%)

Application site vesicles (1.6%)

Application site pain (1.1%)

For topical use only

Not for oral, ophthalmic, or intravaginal use

Instruct patient to avoid using nail polish or cosmetic nail products

Persistent local pain, irritation, or dermatitis may develop; contact health provider if it occurs

Data are not available for use during pregnancy to inform any drug associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes

Unknown if excreted in human milk

Specific maximum dosage information not available.

Specific maximum dosage information not available.

Specific maximum dosage information not available.

6 to 12 years: Specific maximum dosage information not available.
1 to 5 years: Safety and efficacy have not been established.

Safety and efficacy have not been established.

Safety and efficacy have not been established.

Efinaconazole

topical solution

• 10%